Alliancebernstein L.P. Allakos Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Allakos Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 33,830 shares of ALLK stock, worth $33,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,830

Previous 33,830 -0.0%

Holding current value

$33,830

Previous $92,000 54.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $17 - $31	-10 Reduced 0.03%	33,830 $92,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $31,843 - $82,972	14,950 Added 79.14%	33,840 $76,000
Q2 2023 Aug 15, 2023	BUY	$3.6 - $5.25 $68,004 - $99,172	18,890 New	18,890 $82,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $101,946 - $240,749	-39,210 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $99,425 - $192,001	-19,572 Reduced 33.3%	39,210 $223,000

Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $5.26 Million - $68.8 Million	-615,190 Reduced 91.28%	58,782 $575,000
Q3 2021 Nov 10, 2021	BUY	$76.53 - $110.43 $7.49 Million - $10.8 Million	97,928 Added 17.0%	673,972 $71.4 Million
Q2 2021 Jul 30, 2021	BUY	$85.37 - $114.1 $5.57 Million - $7.45 Million	65,294 Added 12.78%	576,044 $49.2 Million
Q1 2021 May 06, 2021	BUY	$109.73 - $153.66 $1.43 Million - $2.01 Million	13,076 Added 2.63%	510,750 $58.6 Million
Q4 2020 Feb 08, 2021	SELL	$79.58 - $152.45 $3.1 Million - $5.95 Million	-39,005 Reduced 7.27%	497,674 $69.7 Million
Q3 2020 Nov 12, 2020	BUY	$66.43 - $90.99 $5.35 Million - $7.33 Million	80,583 Added 17.67%	536,679 $43.7 Million
Q2 2020 Aug 13, 2020	BUY	$44.04 - $80.69 $3.44 Million - $6.31 Million	78,156 Added 20.68%	456,096 $32.8 Million
Q1 2020 May 14, 2020	BUY	$44.49 - $93.39 $2.37 Million - $4.97 Million	53,186 Added 16.38%	377,940 $16.8 Million
Q4 2019 Feb 18, 2020	SELL	$66.49 - $137.73 $932,322 - $1.93 Million	-14,022 Reduced 4.14%	324,754 $31 Million
Q3 2019 Nov 14, 2019	SELL	$31.0 - $89.73 $5.07 Million - $14.7 Million	-163,655 Reduced 32.57%	338,776 $26.6 Million
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $2.77 Million - $3.44 Million	76,868 Added 18.06%	502,431 $21.8 Million
Q1 2019 May 14, 2019	BUY	$33.79 - $51.99 $5.78 Million - $8.89 Million	171,067 Added 67.22%	425,563 $17.2 Million
Q4 2018 Feb 13, 2019	SELL	$31.59 - $62.65 $2.12 Million - $4.21 Million	-67,201 Reduced 20.89%	254,496 $13.3 Million
Q3 2018 Nov 08, 2018	BUY	$31.25 - $47.64 $10.1 Million - $15.3 Million	321,697 New	321,697 $14.5 Million

Others Institutions Holding ALLK

# of Institutions

104

Shares Held

77.4M

Call Options Held

70.7K

Put Options Held

2.8K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $84.7M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Allakos Inc. Transaction History